OTCPK:BDUUY (Thailand)
Â
Business Description
Bangkok Dusit Medical Services PCL
NAICS : 622110
Compare
Compare
Traded in other countries / regions
6DM1.Germany
•
BDMS.Thailand
•
BDULF.USA
Description
Bangkok Dusit Medical Services PCL operates a network of hospitals throughout Thailand under the Bangkok Hospital, Phyathai Hospital, Samitivej Hospital, Paolo Hospital, BNH Hospital, and Royal International Hospital brands. In addition to the firm's core hospital business, it operates a variety of other businesses. The other businesses support the hospital business and include a medical laboratory and manufacture and distribution of medicine and pharmaceutical products. Bangkok Dusit's hospital operations generate the vast majority of its revenue.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.72 | |||||
| Equity-to-Asset | 0.64 | |||||
| Debt-to-Equity | 0.22 | |||||
| Debt-to-EBITDA | 0.85 | |||||
| Interest Coverage | 25.91 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 7.93 | |||||
| Beneish M-Score | -2.47 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -1.9 | |||||
| 3-Year EBITDA Growth Rate | -3 | |||||
| 3-Year EPS without NRI Growth Rate | -5.4 | |||||
| 3-Year FCF Growth Rate | 12 | |||||
| 3-Year Book Growth Rate | 5.5 | |||||
| Future 3-5Y Total Revenue Growth Rate Industry Rank | 6.42 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 3.85 | |||||
| 9-Day RSI | 3.15 | |||||
| 14-Day RSI | 3.37 | |||||
| 6-1 Month Momentum % | 4.15 | |||||
| 12-1 Month Momentum % | 29.68 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.18 | |||||
| Quick Ratio | 1.09 | |||||
| Cash Ratio | 0.6 | |||||
| Days Inventory | 12.47 | |||||
| Days Sales Outstanding | 39.49 | |||||
| Days Payable | 28.35 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.82 | |||||
| Dividend Payout Ratio | 0.96 | |||||
| 3-Year Dividend Growth Rate | 30.5 | |||||
| Forward Dividend Yield % | 1.82 | |||||
| 5-Year Yield-on-Cost % | 3.22 | |||||
| 3-Year Average Share Buyback Ratio | -0.5 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 36.59 | |||||
| Operating Margin % | 18.31 | |||||
| Net Margin % | 13.47 | |||||
| ROE % | 14.27 | |||||
| ROA % | 9.24 | |||||
| ROIC % | 11.82 | |||||
| ROC (Joel Greenblatt) % | 20.15 | |||||
| ROCE % | 14.92 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 37.86 | |||||
| Forward PE Ratio | 33.78 | |||||
| PE Ratio without NRI | 37.86 | |||||
| Shiller PE Ratio | 42.33 | |||||
| Price-to-Owner-Earnings | 42.84 | |||||
| PEG Ratio | 94.65 | |||||
| PS Ratio | 5.12 | |||||
| PB Ratio | 5.36 | |||||
| Price-to-Tangible-Book | 6.88 | |||||
| Price-to-Free-Cash-Flow | 34.08 | |||||
| Price-to-Operating-Cash-Flow | 25.11 | |||||
| EV-to-EBIT | 28.08 | |||||
| EV-to-Forward-EBIT | 30.04 | |||||
| EV-to-EBITDA | 20.61 | |||||
| EV-to-Forward-EBITDA | 21.38 | |||||
| EV-to-Revenue | 5.18 | |||||
| EV-to-Forward-Revenue | 5.17 | |||||
| EV-to-FCF | 34.47 | |||||
| Price-to-Projected-FCF | 3.72 | |||||
| Price-to-Median-PS-Value | 1.02 | |||||
| Price-to-Graham-Number | 3.4 | |||||
| Earnings Yield (Greenblatt) % | 3.56 | |||||
| Forward Rate of Return (Yacktman) % | -0.64 |
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BDUUY
Peter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
Executives
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 2,597.734 | ||
| EPS (TTM) ($) | 0.885 | ||
| Beta | 0.03 | ||
| Volatility % | 16.55 | ||
| 14-Day RSI | 3.37 | ||
| 14-Day ATR ($) | 0.002155 | ||
| 20-Day SMA ($) | 30.15 | ||
| 12-1 Month Momentum % | 29.68 | ||
| 52-Week Range ($) | 23.25 - 30.53 | ||
| Shares Outstanding (Mil) | 397.3 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bangkok Dusit Medical Services PCL Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bangkok Dusit Medical Services PCL Analysis
Share your researchHeadlines
See More
No news.